A rterial hypertension is a risk factor for sudden cardiac death. Moreover, among hypertensives, this risk is increased further in those with left ventricular hypertrophy. 1, 2 The molecular background of cardiac hypertrophy has been associated with changes in myocardial gene expression as well as activation of the tissue renin-angiotensin system and the sympathetic nervous system. The sodium pump is of major importance for active ion transport across the sarcolemma and contributes to the electrical and contractile function of the myocardium. Low concentrations of ouabain, via partial inhibition of the Na pump, cause a small increase in intracellular Na, affect sarcolemmal Na-Ca exchange, and lead to an increase in intracellular Ca and contractility. The rise in cell Ca 2ϩ stimulates the signal transduction pathways that regulate the expression of growth-related genes in heart. 3 It has recently been shown that the incubation of cultured rat neonatal cardiac myocytes with nontoxic concentrations of ouabain induces the transcription of some cardiac earlyresponse proto-oncogenes and late-response fetal genes, 4, 5 which have been implicated as markers of myocyte hypertrophic growth. In contrast with these findings, other investigators have demonstrated that the acute inotropic effect of ouabain is associated with the inhibition of protein synthesis in papillary muscle of adult rats. 6 Evaluation of the controversy between these 2 types of findings should take into account the differences between experimental conditions that may, per se, affect the type of response and the variables measured. There is no doubt, however, that the long-term effect triggered by increased load is toward hypertrophy and not toward inhibition of protein synthesis.
It was recently shown that the human circulation contains an isomer of ouabain or a closely related isomer. 7, 8 This endogenous ouabain (ouabainlike factor [OLF] ) has been quantified both in pure form and in mammalian tissues and small volumes of plasma via independent assays. 7, 9 Functionally, OLF is a high-affinity, reversible, and specific inhibitor of the Na pump, with inotropic and vasopressor activity. 7, 10 Elevated plasma OLF levels have been described in Ϸ45% of patients who were initially diagnosed with essential hypertension (EH) and referred for possible secondary hypertension. 11 The induction of hypertrophic characteristics in vitro by ouabain and the frequency of increased circulating OLF and left ventricular mass among patients with EH led us to consider the possibility of a link between these phenomena. Accordingly, this study reports results of the first large-scale investigation of circulating OLF in patients with EH in whom parallel measurements of left ventricular mass and function have been performed.
Methods

Patient Selection and Blood Pressure Measurements
Normotensive healthy subjects (nϭ110, 23 to 50 years of age) who attended the San Raffaele Hospital in Milan gave informed consent for blood sampling. Patients with EH were recruited at random from our outpatient clinics by 2 of us (P.M. and D.C.). Secondary hypertension was excluded by routine blood chemistry, urinalysis, and renal echography. Subjects were excluded if they had a medical history that included myocardial infarction, congestive heart failure, stroke, diabetes mellitus, liver disease, use of oral contraceptives, or the abuse of drugs or alcohol. A large portion of the hypertensive patients (nϭ100) had developed high blood pressure within the previous 2 years and had not previously received antihypertensive drugs. Treated patients discontinued medication for Ն3 months before entering the study. During this period, blood pressure was monitored every 2 weeks and therapy was started; the patient was excluded from the study if diastolic blood pressure (DBP) increased Ͼ15 mm Hg or reached 105 mm Hg. Office blood pressures were Ͼ145/95 mm Hg on Ն3 occasions in all patients enrolled in the study. Furthermore, a 24-hour ambulatory blood pressure recording (Spacelab 90207) was performed in all patients to confirm the diagnosis of hypertension. Subjects whose mean daytime blood pressure was Ͼ140/90 mm Hg were included. Inclusion and exclusion criteria led to 128 patients with EH. All were instructed to consume a diet with a stable sodium content of Ϸ150 mmol/d for Ϸ1 month before the study. The study was approved by the Ethical Committee of the San Raffaele Hospital, and informed consent was obtained from each individual.
Sample Collection and Immunoassays
Venous blood for measurement of plasma renin activity (PRA), aldosterone, OLF, Na, and K concentrations was collected in tubes that contained 200 L of Na 2 EDTA after the subject had been lying quietly in the supine position for Ն1 hour. Samples were centrifuged immediately at 3000g at 4°C for 15 minutes, and the supernatant was collected and frozen at Ϫ20°C until assay. Twenty-four-hour urine samples were collected starting the day before at 8:00 AM, and samples were removed for Na, K, and creatinine assay. PRA and aldosterone were determined by commercial assays (Sorin), and Na, K, and creatinine were determined by autoanalyzer. OLF was extracted from plasma and measured with a specific radioimmunoassay. The antiserum used was shown to cross-react fully with human and rat OLF. 7, 9 
Measurement of Left Ventricular Mass
Patients with EH were submitted to monodimensional and bidimensional echocardiography (Hewlett-Packard SONOS 2500) by trained operators (P.S. and D.C.). Operators were blinded to the status of the patients. Left ventricular internal diameter and septal and posterior wall thickness were measured at end diastole and end systole, according to the American Society of Echocardiography guidelines. Left ventricular mass was calculated at end-diastole by use of the Devereux correction to the American Society of Echocardiography cube left ventricular mass formula. 12 
Statistical Analyses
Values are expressed as meanϮSEM. Comparison of the different groups of patients was performed with 1-way ANOVA followed by a posteriori multiple comparison with Fisher's least significant difference test. Tests for bimodality were performed with the method of Day 13 by a program written ad hoc for an Apple Macintosh personal computer. The program assesses the presence of multiple normal distributions in the data and computes the means, standard deviations, and proportion of each subpopulation to the total population. To investigate the relationship between plasma OLF and the other known variables that may affect left ventricular mass, multiple regression analysis was performed with a probability of inclusion criterion of 0.05. Table 1 presents the clinical characteristics of the 110 normotensives and 128 hypertensives studied. Office blood pressures were used during the recruitment of the study subjects. The hypertensives were similar to the normotensives but included a higher proportion of men than women. Circulating OLF values were significantly higher (PϽ0.0001) in the hypertensive patients. However, plasma levels of OLF did not differ between normotensive men (286Ϯ17 pmol/L) and women (259Ϯ17 pmol/L) or between their hypertensive counterparts (389Ϯ21 versus 310Ϯ45 pmol/L, respectively). Thus, the difference in circulating OLF between the normotensive and hypertensives did not appear to be gender related. Plasma OLF in hypertensive men and women was higher than in their normotensive controls, but only the latter reached statistical significance (Pϭ0.014). Urinary Na and K excretion were slightly greater in EH, but the difference was not significant.
Results
The distribution of plasma OLF was unimodal in normotensives ( Figure 1 , top), with a mean of 253Ϯ53 pmol/L; the plasma concentration ranged between 0 (the threshold concentration in the RIA was Ϸ30 pmol/L) and 600 pmol/L. Plasma OLF levels ranged from 53 to 930 pmol/L in hypertensives (Figure 1, bottom) . The distribu- 
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tion of OLF values fit significantly better in a bimodal (PϽ0.01) than a unimodal or trimodal distribution. The computed plasma OLF for the first mode was 207Ϯ74 pmol/L, a value similar to that observed in the normotensives (253Ϯ53 pmol/L). The plasma OLF of the higher mode was 540Ϯ197 pmol/L. Accordingly, the hypertensives were split into 2 subgroups by drawing 2 normal distributions. We defined hypertensive patients with plasma OLF levels of Ͻ281 pmol/L as "normal" on the basis of the similarity of their circulating levels to those observed among the normotensive group. The cutoff value used was calculated from the mean of the normal mode plus 1 SD (207ϩ74 pmol/L). Similarly, we apportioned hypertensive patients into the "high" subgroup when the OLF was Ͼ343 pmol/L. This value was calculated from the mean of the higher mode minus 1 SD (540Ϫ197 pmol/L). Among EH subjects, the normal-and high-OLF subgroups contained 60 (49 men and 11 women) and 62 (54 men and 8 women) individuals, respectively. The 6 patients whose plasma OLF levels ranged between 281 and 343 pmol/L were excluded from further subgroup analyses.
In the combined group of normals and all patients, plasma OLF correlated positively with systolic blood pressure (SBP) (R 2 ϭ5.6%, Pϭ0.0004) and DBP (R 2 ϭ4.5%, Pϭ0.0015), although only half of the patients exhibited elevated plasma OLF. Table 2 presents the major clinical characteristics of the 2 OLF subgroups of EH patients. The ambulatory values for 24-hour SBP and DBP were lower than the office pressures recorded during patient recruitment (Table 1 ). Both ambulatory SBP and DBP were higher in the subgroup with elevated OLF, but only the latter reached statistical significance. All other variables (creatinine clearance, sodium excretion, PRA, and plasma aldosterone) were similar in the 2 OLF subgroups between normal-and high-OLF EH. Figure 2 shows the echocardiographic parameters in the 2 subgroups of EH patients. The left ventricular mass index was substantially greater in EH with high OLF (102Ϯ3.3 g/m 2 ) than in the subgroup with normal OLF (86Ϯ2.5 g/m 2 ), PϽ0.001. With gender-specific cutoffs to define left ventricular hypertrophy (LVH) (women 106 g/m 2 and men 114 g/m 2 ), 11 12 (10 men and 2 women) (80%) of the 15 (13 men and 2 women) patients with LVH were in the high-OLF subgroup. Thus, the relative risk of LVH was 4.6-fold higher in the high-OLF subgroup. As shown in Figure 2B and 2C, stroke volume was higher and heart rate was lower in the subgroup of patients with high plasma OLF. other echocardiographic findings for cardiac dimensions and function in the 2 subgroups. In the subgroup with high plasma OLF, the mean septum thickness, end-diastolic diameter, end-diastolic volume (EDV), and cardiac output were greater than in the subgroup with normal OLF. Although not measured simultaneously, both the higher blood pressure and higher cardiac output in the high-OLF subgroup suggest that total peripheral resistance also should have been greater. Ejection fraction did not differ between the subgroups.
Plasma OLF and left ventricular mass index (LVMI) correlated positively (R 2 ϭ0.14; Pϭ0.0001) in the entire group with hypertension ( Figure 3 ), whereas heart rate and plasma OLF correlated inversely (R 2 ϭ0.17, Pϭ0.0001). A positive but weak correlation was present between plasma OLF and left ventricular EDV (R 2 ϭ3.4%, Pϭ0.038, not shown). To estimate the independent contribution of the measured variables to the variance of LVMI, a multiple regression analysis was performed with gender, age, body mass index, 24-hour ambulatory SBP, and plasma OLF as independent variables (Table 4) . Among these variables, only 24-hour ambulatory SBP, OLF, age, and body mass index contributed significantly to the variance of LVMI, whereas gender did not. As for the obvious reason that SBP and DBP are correlated, only 1 pressure at a time was entered into the model. We chose SBP because it appears to be the major determinant of LVMI, but DBP was also tested. The LVMI variance explained independently by 24-hour ambulatory DBP was 12.4%, which was similar to that obtained for 24-hour ambulatory SBP.
Discussion
The major new findings of the present studies are as follows: (1) Patients with uncomplicated essential hypertension of Figure 2 . LVMI (A), stroke volume (B), and heart rate (C) in hypertensive patients with normal and high plasma OLF values. LVMI and stroke volume were greater in hypertensives with high plasma OLF, although heart rate was significantly lower. 
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short duration have, on the average, elevated circulating OLF levels that are positively correlated with both blood pressure and left ventricular mass. (2) The frequency distribution of plasma OLF is bimodal in EH, whereas it is unimodal in normotensives. The mean of the primary mode was similar in both normotensives and EH patients, but Ϸ50% of the EH patients had high circulating levels of OLF that were described by an additional mode. The observation that elevated plasma OLF is not found in all EH patients suggests that the raised levels are not simply secondary to hypertension but are consistent with the present view that EH is multi-etiologic. 14 The proportion of EH patients with high plasma OLF in this study is similar to that found in a previous study (Ϸ45%) 11 in which the patients had EH that was more severe, more complicated, and of longer duration. The frequency with which elevated plasma OLF is observed among unselected patients with EH is notable and suggests that this sodium pump inhibitor either is a marker for a large, previously unrecognized, intermediate phenotype or that it is related to the pathogenesis of elevated blood pressure in the afflicted individuals. (3) Multiple regression analyses revealed that 13.2% and 11.6% of the variance of left ventricular mass is explained by 24-hour SBP and OLF, respectively. The importance of the former relationship is widely recognized and was verified in this study with patients whose hypertension was of short duration and free from complications. Under these conditions, the specific linkage of OLF with cardiac mass independent of blood pressure now reinforces the possibility that sodium pump inhibitors may be linked with cardiac structure in vivo in addition to its known effects on cardiac function. Human OLF is a specific, high-affinity, and reversible inhibitor of the sodium pump that is an isomer of ouabain. 7, 8 We have shown that our method measures human OLF specifically and quantitatively 7 and that a direct relationship between immunoreactivity and biological activity exists under extraction and assay conditions identical to those used in this study. 9 Similar radioimmunoassay methods have been used to determine serum digoxin concentrations. In the elderly with heart failure, serum digoxin levels that ranged between 0.4 and 1 ng/mL (ie, 0.52 to 1.3 nmol/L) were related to stroke volume. 15, 16 The therapeutic concentrations of digoxin overlap those of the high mode of distribution for plasma OLF in the EH patients. Thus, the relationships between OLF and heart rate and stroke volume that we observed are comparable to those obtained with therapeutic concentrations of digitalis glycosides. 15, 16 The stimulus for the elevated circulating OLF levels in a subgroup of patients is unknown. Increased secretion and diminished renal or metabolic clearance are possibilities not addressed by the design of our study and will require future investigation. Increased salt intake, renal failure, and raised extracellular fluid volumes have been suggested as a stimulus to increase OLF. 17 However, neither creatinine clearance nor sodium excretion differed in EH with normal and high OLF. Thus, overt impairment of renal function and variation of sodium intake within the ranges measured can be excluded. Moreover, acute expansion of extracellular fluid volume in dogs and in humans did not raise plasma OLF. 18, 19 Nevertheless, increased circulating levels of OLF were observed in patients with volumesensitive hypertension and congestive heart failure, which raises the possibility that a chronic as opposed to an acute tendency for expansion of fluid volume may be relevant. 8, 16 EDV was greater in EH patients with high OLF, which suggests increased central blood volume. Multiple regression analysis suggested that OLF accounted for a small portion (3.4%) of EDV variance in patients with EH.
Among the EH patients, the high-OLF subgroup exhibited increased 24-hour DBP, left ventricular mass index, and stroke volume, although their heart rates were lower. All other variables, including PRA and aldosterone levels, did not differ between the 2 groups. Multiple regression analysis demonstrated that OLF contributed to left ventricular mass independent of its relationship with blood pressure. Therefore, the nature of the observed relationship between cardiac parameters, blood pressure, and circulating OLF is of interest. The experimental design used suggests a possible cause-and-effect relationship. However, long-term clinical studies similar to those that demonstrated the role of elevated blood pressure in raising cardiac mass will be required to address causality. Nevertheless, the observation that the patients with elevated OLF have higher 24-hour DBP is noteworthy. In both normotensives and hypertensives, the long-term DBP is correlated with the risk of cardiovascular and cerebrovascular disease without apparent threshold. 20, 21 Differences of as little as 4 to 6 mm Hg in DBP have been linked with significant risk outcomes. 20 -22 Moreover, in addition to higher 24-hour DBP, the EH patients with high OLF had larger left ventricular mass, which itself has been shown to worsen outcome. 1,2 Thus, irrespective of whether the links of OLF with blood pressure and cardiac structure are causal, high OLF is a potential marker for heightened overall risk of premature morbidity and mortality.
A number of observations do, however, demonstrate cause-and-effect relationships for ouabain, blood pressure, and cardiac mass in other settings. As one example, prolonged infusion of low doses of plant ouabain induced sustained hypertension in normal rats. 23 The steady-state plasma levels of ouabain were dose-dependently related to blood pressure and embrace the circulating levels of OLF in the high-OLF patient subgroup studied here. Second, a novel class of antihypertensive agents that are antagonists of ouabain has been described recently. These agents blocked the chronic hypertensinogenic and renal effects of prolonged ouabain administration. 24, 25 Third, inhibition of the majority of sodium pumps by ouabain leads to marked increases in cell Na and inhibition of protein synthesis, 6 the latter associated with K loss and eventual cell death; whereas studies conducted in cultured neonatal rat cardiac myocytes demonstrate that concentrations of ouabain that inhibit a small fraction of the available sodium pumps activate the expression of growth-related genes and induces cellular hypertrophy. 4, 5 These results suggest that ouabain affects the signal transduction pathways through the interaction with gene regulatory mechanisms specifically localized in cardiac myocytes. 4 Similarly, cellular hypertrophy can be induced in cardiac and arterial myocytes by raising the sodium concentration in their cell culture media. 26 These reports emphasize the role of small sustained increases in cell sodium in accelerating cell growth. In apparent contrast with these findings, others demonstrated that the acute inotropic effect of ouabain in papillary muscle of adult ferret already stimulated to maximum isometric tension is associated with slight inhibition of protein synthesis. The different experimental conditions should at least in part be responsible for the discrepancies. In addition to induced isometric contraction, it may be possible that the cardiomyocytes have to face K ϩ loss-dependent reduction of protein synthesis. Moreover, the long-term effect that is trigged by an increased load is hypertrophy and not inhibition of protein synthesis.
In summary, among patients with uncomplicated EH, Ϸ50% had elevated circulating levels of an OLF. This subgroup of patients was characterized by greater DBP, left ventricular mass, and stroke volume and lower heart rate. Elevated circulating OLF appears to be a new factor that contributes to increased risk among patients with EH. Additional cross-sectional as well as longitudinal investigations are indicated.
